|Year : 2021 | Volume
| Issue : 75 | Page : 428-437
Systematic analysis of bioactive components of Distinct medicinal organs of mulberry by high-performance liquid chromatography with electrospray ionization mass spectrometry and molecular docking
Jingqiong Wan1, Shengrong Cheng2, Yuting Wang2, Chongwei Wen2, Yuan Wei2, Dujun Wang3, Zhen Ouyang4
1 Food Science and Engineering, School of Food and Biological Engineering, Jiangsu University, Zhenjiang, China
2 Chinese Materia Medica, School of Pharmacy, Jiangsu University, Zhenjiang, China
3 Food Science and Engineering, School of Marine and Biological Engineering, Yancheng Institute of Technology, Yancheng, China
4 Food Science and Engineering, School of Food and Biological Engineering, Jiangsu University; Chinese Materia Medica, School of Pharmacy, Jiangsu University, Zhenjiang, China
|Date of Submission||17-Dec-2020|
|Date of Decision||21-Jan-2021|
|Date of Acceptance||22-Apr-2021|
|Date of Web Publication||11-Nov-2021|
School of Pharmacy, Jiangsu University, 301 Xuefu Road, Zhenjiang, Jiangsu, 212013
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Mori Folium, Mori Ramulus, Mori Fructus, and Mori Cortex are traditional Chinese medicines derived from distinct organs of mulberry (Morus alba L.). Intriguingly, their efficacies are different. Objectives: In this study, we aimed to systematically analyze the similarities and differences in the chemical composition of the aforementioned four medicines and to explore their bioactive components of anti-inflammatory and antitussive activity. Materials and Methods: High-performance liquid chromatography with electrospray ionization mass spectrometry (HPLC-ESI-MSn) was used to identify the various compounds present in each of the four medicines from the methanolic extracts and different polar fractions of aqueous extracts. Moreover, the identified compounds were docked against anti-inflammatory or antitussive targets by means of the molecular docking tool, molecular operating environment 2018. Results: A total of 77 compounds were identified from the four study materials, of which 30 were identified in Mori Folium, 27 compounds in Mori Ramulus, 23 compounds in Mori Fructus, and 46 compounds in Mori Cortex, and they had 14, 4, 3, and 26 compounds that were specific to them, respectively. The results of molecular docking indicated that quercetin, chlorogenic acid, and isoquercitrin, the shared compounds of the four medicines showed strong anti-inflammatory activity. Of note, the top 10% of compounds with better anti-inflammatory activity were mostly identified in Mori Cortex, whereas the least in Mori Fructus. Moreover, out of the top 10% of compounds with better antitussive activity, 11 compounds were identified in Mori Cortex, and only 2 or 3 compounds were identified in the other three medicines. Conclusion: The results of this study are consistent with the clinical application of the four study medicines derived from mulberry, which further supports the fact that their efficacy is dependent on their chemical composition.
Keywords: Bioactive components, high-performance liquid chromatography with electrospray ionization mass spectrometry, molecular docking, Mori cortex, mulberry
|How to cite this article:|
Wan J, Cheng S, Wang Y, Wen C, Wei Y, Wang D, Ouyang Z. Systematic analysis of bioactive components of Distinct medicinal organs of mulberry by high-performance liquid chromatography with electrospray ionization mass spectrometry and molecular docking. Phcog Mag 2021;17:428-37
|How to cite this URL:|
Wan J, Cheng S, Wang Y, Wen C, Wei Y, Wang D, Ouyang Z. Systematic analysis of bioactive components of Distinct medicinal organs of mulberry by high-performance liquid chromatography with electrospray ionization mass spectrometry and molecular docking. Phcog Mag [serial online] 2021 [cited 2022 Sep 30];17:428-37. Available from: http://www.phcog.com/text.asp?2021/17/75/428/330222
- The chemical composition and potential compounds present in the four medicinal parts of mulberry were investigated
- A total of 30 compounds were identified in Mori Folium, 27 compounds in Mori Ramulus, 23 compounds in Mori Fructus, and 46 compounds in Mori Cortex
- The top 10% of the compounds with better docking effect of anti-inflammatory and antitussive targets were mostly identified in Mori Cortex, which were consistent with clinical application of the four medicines of mulberry
- It further supported the correlation between chemical composition and pharmacodynamics.
Abbreviations used: HPLC-ESI-MSn: High-performance liquid chromatography electrospray ionization mass spectrometry; TCMSP: Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform; BPI: Base peak intensity; MCH: CHCl3-soluble fraction of mulberry; MPE: Petroleum ether-soluble fraction of mulberry; MEA: EtOAc-soluble fraction of mulberry; MBU: N-BuOH-soluble fraction of mulberry; MOE: Molecular Operating Environment.
| Introduction|| |
Mulberry (Morus alba L.) is a Traditional Chinese Medicinal (TCM) plant, and various versions of Chinese Pharmacopoeia record that its dried leaves, shoots, fruits, and root bark can be used as medicines. Among them, the dried leaves of mulberry known as Mori Folium, clinically used for improving eyesight (i.e., eyes with bloodshot or dry eyes) and as well as for alleviating anemopyretic cold, lung heat disease with dry cough, headache, and vertigo disease. Next, the dried shoot of mulberry, known as Mori Ramulus, used in the treatment of rheumatism, as well as numbness in the shoulder and arm joints. Next, the dried fruits of mulberry, known as Mori Fructus, used in treating in deficiency of liver and kidney, dizziness and tinnitus, palpitations and insomnia, internal heat and intestinal dryness with constipation. Finally, the dried root bark of the mulberry, known as Mori Cortex, used for lung heat disease with panting and cough, as well as for edema and oliguria.
Pharmacological studies have shown that the four distinct parts of mulberry exhibit different bioactivities with regard to lowering of blood sugar and fatty acid components, anti-inflammatory, antioxidant, and antitumor activities, as well as with immunoregulation as they contain inherent bioactive compounds including flavonoids, alkaloids, polysaccharides, coumarins, steroids, benzofuran derivatives, Diels-Alder adducts, terpenes, and volatile oils.,,, Analysis of the chemical composition of mulberry has been studied extensively, for example, Zhao et al. established fingerprint patterns and common pattern maps of different medicinal parts of mulberry. Their results showed that there were 12 common peaks in Mori Folium, 11 in Mori Ramulus, 8 in Mori Fructus, and 10 in Mori Cortex. Furthermore, Han et al. showed that the aforementioned medicines have four common volatile compounds including hexanal, 1-octen-3-ol, methylheptenone, and nonanal. They also identified some unique compounds such as camphor and eugenol in Mori Folium, menthol in Mori Fructus, and terpineol and (-)-4-terpineol in Mori Cortex.
Therefore, the pharmacological effect and clinical application among the distinct medicinal organs of mulberry depends on the similarity and differences in their chemical composition. However, so far, there is lack of comprehensive and systematic analysis with regard to the chemical composition of mulberry. Molecular docking technology has been proven to be an effective method to develop and study the mechanism of curative compounds in TCM., In this study, high-performance liquid chromatography with electrospray ionization mass spectrometric detection (HPLC-ESI-MSn) was used to conduct a comprehensive and systematic research on the chemical composition of Mori Folium, Mori Ramulus, Mori Fructus, and Mori Cortex in order to establish a compound library of distinct medicinal parts of mulberry. In addition, we used molecular docking technology to virtually screen the components responsible for anti-inflammatory and antitussive activity for providing a basis for the quality evaluation and drug design from different parts of mulberry.
| Materials and Methods|| |
Chemicals and reagents
The dried leaves, shoots, fruits, and root bark from the same tree of M. alba L. from mulberry field of Jiangsu University were collected during their traditional harvest period and authenticated by Professor Zhen Ouyang. Methanol, formic acid, glacial acetic acid, petroleum ether, chloroform, and ethyl acetate were of analytical grade and purchased from Sinopharm Group Reagent Co., Ltd. (Shanghai, China), and HPLC-grade methanol and HPLC-grade acetonitrile were purchased from TEAD.
Analysis of methanolic extracts by high-performance liquid chromatography with electrospray ionization mass spectrometry
Preparation of samples
The coarse powder (1.0 g, passed through No. 3 sieve) of Mori Folium, Mori Ramulus, Mori Fructus, and Mori Cortex were extracted in 20 mL of methanol under reflux at 80°C for 2 h to obtain respective methanolic extracts (MMe). The extracts were filtered through 0.45 μm membranes and then used directly for the HPLC-ESI-MSn analysis.
HPLC and MS conditions
HPLC was performed using Agilent 1260 (Agilent, USA), and [Table 1] shows the experimental conditions applied for the HPLC analysis. The MS conditions were negative ion mode with 3.5 Kv source voltage; sheath gas (N2) flow rate was 36 au; auxiliary gas (N2) flow rate was 10 au; collision gas was helium; capillary temperature was 325°C; capillary voltage was −30 V; and full ion scanning mode with scanning range of 50–1,000 m/z. The MS/MS collision energy was 50%. Data processing was conducted by Xcalibur software version 2.0.7 (Thermo Fisher Scientific, USA).
|Table 1: The high performance liquid chromatography conditions of methanol extracts of the four medicinal organs of mulberry|
Click here to view
Analysis of different polar extracts by high-performance liquid chromatography with electrospray ionization mass spectrometry
Preparation of samples
The coarse powder (50.0 g, passed through No. 3 sieve) of Mori Folium, Mori Ramulus, Mori Fructus, and Mori Cortex were thrice extracted in 500 mL of distilled water under reflux at 100°C and 2 h. Subsequently, the combined filtrates were concentrated by a rotary evaporator at 55°C (Buchi-200, BUCHI Labortechnik AG, Switzerland, Germany) to obtain the concentrated solution of each of the study material.
Next, the same volume of petroleum ether (PET), chloroform (CHCl3), ethyl acetate (EtOAc), and n-butanol (n-BuOH) was added to each of the solutions in a successive extraction step-by-step for three times and then the extracts were combined separately. Next, the extracts were concentrated under vacuum, which was followed by freeze-drying for 12 h using a vacuum freeze dryer (ALPHA 1–2 LD, Marin Christ, Osterode, Germany). Finally, each of the resultant products were dissolved in an appropriate volume of methanol to obtain the PET-soluble fraction (MPE), CHCl3-soluble fraction (MCH), EtOAc-soluble fraction (MEA), and n-BuOH-soluble fraction (MBU). The fractions were filtered through 0.45-μm membrane, and the filtrates were used as samples for HPLC-ESI-MSn analysis.
High-performance liquid chromatography and mass spectrometry conditions
HPLC analysis was performed using Agilent 1260 (Agilent, USA), and [Table 2] shows the MS condition.
|Table 2: The high performance liquid chromatography conditions of different polar extracts of the four medicinal organs of mulberry|
Click here to view
Molecular docking studies
The 3D structures of the compounds were searched in the TCM system pharmacology (TCMSP, http://lsp.nwu.edu.cn/tcmsp.php) and PubChem (https://www.ncbi.nlm.nih.gov) databases. The Chem3D Pro 14.0 software (Cambridge Soft, Waltham, MA, USA) was used for the transformation of the standard 3D structure module. The molecular operating environment (MOE 2018, Chemical Computing Group Inc., Montreal, Canada) was used to construct ligand database, and force field was adjusted to Amber 10. The energy and conformation majorization were done to all compounds by MOE Energy Minimize.
According to the TTD database (http://db.idrblab.net/ttd/) and related literature, inducible nitric oxide synthase (iNOS), tumor necrosis factor (TNF)-α, interleukin (IL)-1 β, and IL-6 were used as anti-inflammatory targets.,, The X-ray crystallographic structures of the aforementioned proteins (PDB codes: 3HR4, 2AZ5, 1ALU, 3O4O, 1F0J, and 2R4S) were downloaded from the Protein Data Bank (PDB, www.rcsb.org). MOE 2018 was used to preprocess the original structure of the target protein, force field was set to Amber 99, hydrogen atoms were first added, all monosaccharide, and water molecules were removed, and energy optimization was done to all compounds.
Docking was done in MOE-Dock module by the settings of placement function (Triangle Matcher) and scoring function (London dG). The rest of the parameters were kept as default, and then, all atoms were docked. The ligand and the receptor were semi-flexibly docked with their associated scores indicated based on their free energy of binding and their subsequent interactions with the surrounding amino acids. The docking scores of all the compounds with 4 anti-inflammatory targets and 2 antitussive targets were obtained. The lower the score, the more stable the ligand binds to the receptor. Notably, the binding activity of the compound to the target was evaluated by the scores and the number of combinative amino acid residues.
| Results|| |
Analysis of methanolic extracts via high-performance liquid chromatography with electrospray ionization mass spectrometry
The chemical composition of MMe of the study materials was analyzed using HPLC-ESI-MSn. According to the results, most of the compounds had a better response under ESI negative ion mode conditions [Figure 1] and [Figure 2]. According to the retention times of each chromatographic peak, ion peak, and main fragment peak information, combined with relevant literature data and the database of natural products, such as TCMSP, TCM, Mass Bank and SciFinder, and so on, a total of 42 compounds were identified in methanol extracts of the study materials [Table 3]. These included 27 flavonoids, 5 phenolic acids, 3 Diels-Alder-type adducts, 2 stilbenes, 4 2-arylbenzofurans, and 1 triterpene. Among them, 16 compounds were identified in Mori Folium, 13 compounds in Mori Ramulus, nine compounds in Mori Fructus, and 26 compounds in Mori Cortex.
|Figure 1: The high-performance liquid chromatography chromatogram of MME of Mori Folium (A1), Mori Ramulus (B1), Mori Fructus (C1) and Mori Cortex (D1)|
Click here to view
|Figure 2: The base peak intensity chromatogram of MME of Mori Folium (A2), Mori Ramulus (B2), Mori Fructus (C2) and Mori Cortex (D2)|
Click here to view
|Table 3: Identification results of the compounds in methanolic extracts of the four medicinal organs of mulberry|
Click here to view
Analysis of different polar extracts via high-performance liquid chromatography with electrospray ionization mass spectrometry
A total of 50 compounds were identified from different polar fraction of water extracts through HPLC-MSn. In the case of MPE [Figure S1] and [Figure S2], [Table 4], seven compounds were identified, of which 2, 2, 4, and 5 compounds were, respectively, identified from Mori Folium, Mori Ramulus, Mori Fructus, and Mori Cortex. In addition, for the MCH [Figure S3] and [Figure S4], [Table 5], 6 compounds were identified, of which 3, 2, 4, and 2 compounds were respectively identified from Mori Folium, Mori Ramulus, Mori Fructus, and Mori Cortex. Furthermore, 28 compounds were identified in MEA [Figure S5] and [Figure S6], [Table 6], of which 9, 10, 12, 10 compounds were respectively identified from Mori Folium, Mori Ramulus, Mori Fructus, and Mori Cortex. Moreover, 18 compounds were identified in MBU [Figure S7] and [Figure S8], [Table 7], of which a total of 6, 4, 7, and 5 compounds were respectively identified from Mori Folium, Mori Ramulus, Mori Fructus, and Mori Cortex.
|Table 4: Identification results of the compounds in petroleum ether-soluble fraction of mulberry of the four medicinal organs of mulberry|
Click here to view
|Table 5: Identification results of the compounds in chloroform - soluble fraction of mulberry of the four medicinal organs of mulberry|
Click here to view
|Table 6: Identification results of compounds in ethyl acetate-soluble fraction of mulberry of the four medicinal organs of mulberry|
Click here to view
|Table 7: Identification results of compounds in n. butanol.soluble fraction of the four medicinal organs of mulberry|
Click here to view
Importantly, our results showed that four of these compounds were identified in each of the four medicines, namely, 9, 10, 11-trihydroxy-12-octadecenoic acid; eicosanoic acid; isoquercitrin; and mothaxanthin-3-O-β-D-glucoside. Moreover, 12, 3, 8, and 10 characteristic compounds were respectively identified in Mori Folium, Mori Ramulus, Mori Fructus, and Mori Cortex. Of note, 2-arylbenzofuran and flavonoid compounds were mainly identified in MEA and MBU, whereas the fatty acids were mainly identified in MPE and MCH.
Molecular docking of anti-inflammatory and antitussive compounds
[Table 8] shows the molecular docking scores obtained upon docking tested compounds against iNOS, TNF-α, IL-6, and IL-1 β as anti-inflammatory targets. In general, higher docking scores imply stronger activity. Among the 77 compounds docked, chlorogenic acid, mulberroside A, sanggenone C, and morin have been previously reported to inhibit the activity of iNOS.,, Nonetheless, in this study, the results of molecular docking scores showed that cathafuran B, 6”-acetyl astragalin, quercetin, astragalin, 4-benzoic acid 4-O-β-D-glucopyranoside, 6”-O-crotonyl astragalin, and cudraflavanone C had stronger binding ability to iNOS targets as compared with chlorogenic acid, mulberroside A, sanggenone C and morin. Notably, among the top 10% of the compounds docked, 4 compounds were identified in Mori Folium, 2 compounds in Mori Ramulus, 2 compounds in Mori Fructus, and 3 compounds in Mori Cortex. Consequently, cathafuran B showed the strongest binding ability for iNOS [Figure 3]a, as it formed three hydrogen bonds with two amino acid residues (Pro A567 and Arg B90) present in iNOS target.
|Table 8: Docking scores of the compounds bonded with inducible nitric oxide synthase, tumor necrosis factor-alpha, interleukins-6 and interleukins-1 (top 10%)|
Click here to view
|Figure 3: Representation of the best pose of compounds docked with anti-inflammatory target. (a) Cathafuran B docking with inducible nitric oxide synthase target. (b) Cathafuran B docking with tumor necrosis factor-α target. (c) Cathafuran B docking with interleukin interleukin-6 target. (d) Rutin docking with interleukin-1 β target|
Click here to view
Similarly, chlorogenic acid, sanggenone G, sanggenone C, morin, and quercetin have been demonstrated to inhibit the activity of TNF-α;,, however, based on the results of molecular docking scores in this study, cathafuran B, mulberrin K, mulberrin Y, mulberrin O, mulberrofuran G, cyclomulberrochromene, and moracin dimer displayed stronger binding ability to TNF-α than that of the five compounds reported. Nevertheless, among the top 10% of the compounds, that is, 7 compounds, only 1 compound was identified in Mori Ramulus, whereas 6 compounds were identified in Mori Cortex. Cathafuran B showed the best binding ability to TNF-α [Figure 3]b, which was due to its bonds formed with several surrounding amino acids including five hydrogen bonds formed with Lys90, Asp45, Gln47, and Thr77.
According to the literature, chlorogenic acid and sanggenone G and C show good inhibitory against IL-6., In this study, cathafuran B, moracin dimer, isoquercitrin, and mulberrin U exerted stronger binding ability to IL-6 targets than them. Among the top 10% of the compounds with better binding ability to IL-6, 3 compounds were identified in Mori Folium, 2 compounds in Mori Ramulus, 2 compounds in Mori Fructus, and 6 compounds in Mori Cortex. Cathafuran B bonded to Lys120 and IIe136 in IL-6 with two hydrogen bonds, which had the best docking activity [Figure 3]c.
Previous reports indicate that sanggenone C, quercetin, and moracin M show good inhibitory activity against IL-1 β;,, however, our results showed that rutin; quercetin-3-O-β-D-pyranosyl-(1,6)-β-D-glucopyranoside; 6”-O-crotonyl astragalin; cyclomulberrochromene; and mulberrin Y combined strongly with the target protein as compared with quercetin, moracin M, and sanggenone C. Of note, out of the top 10% of the compounds screened, five compounds were identified in Mori Folium, 3 compounds in Mori Ramulus, 3 compounds in Mori Fructus, and 3 compounds in Mori Cortex. Among them, rutin had the best binding ability with IL-1 β [Figure 3]d. It formed eight hydrogen bonds with several surrounding amino acids including Asp AS4, Asp C289, Glu A105, Lys B219, Ser C285, and Asn A108.
[Table 9] shows the results of molecular docking with phosphodiesterase (PDE) 4B and β2 adrenergic receptors as antitussive targets. Among the 77 compounds screened, previous reports indicate that moracin M and sanggenone C are potential inhibitors of PDE 4B; however, the results of our study showed that quinic acid, cathafuran B, mulberrin U, isoquercitrin, ethyl palmitate, sanggenon G, and cryptochlorogenic acid binding to the target protein better than PDE 4B and β2 adrenergic receptors. Among the top 10% of the compounds screened, 3 compounds were identified in Mori Folium, 2 compounds in Mori Ramulus, 2 compounds in Mori Fructus, and 6 compounds in Mori Cortex. Consequently, quinic acid had the best binding stability with PDE 4B target with five hydrogen bonds through Asn 283, Glu 304, Met 347, and Asp 346 [Figure 4]a.
|Table 9: Docking scores of the compounds bonded with phosphodiesterase 4B and β2 adrenergic receptors (top 10%)|
Click here to view
|Figure 4: Representation of the best pose of compounds docked with antibechic target. (a) Quinic acid docked with PDE 4B target. (b) Muberrin U docked with β2 adrenergic receptors target|
Click here to view
The results of molecular docking with β2 adrenergic receptors showed that the top 10% of the compounds with better docking capability were mostly flavonoids that were identified in Mori Cortex. Furthermore, mulberrin U was the best in docking as it forms two hydrogen bonds with Gly A41 and Thr B165 in β2 adrenergic receptor target [Figure 4]b. Of note, mulberrin U was only identified in Mori Cortex.
| Discussion|| |
Identification of compounds from the four medicinal parts of mulberry
A total of 77 compounds were identified from the four medicinal parts of mulberry based on HPLC-MSn analysis. Of them, 42 were flavonoids, 9 were 2-aryl benzofurans, 7 were fatty acids, 5 were coumarins, 5 were phenolic acids, 4 were Diels-Alder-type adducts, 2 were stilbenes, 1 was triterpene, and 2 were other species. Among these compounds, thirty were identified in Mori Folium, 27 compounds in Mori Ramulus, 23 compounds in Mori Fructus, and 46 compounds in Mori Cortex, and they have 14, 4, 3, and 26 exclusive compounds, respectively [Figure 5]. Moreover, it was found that Mori Ramulus and Mori Cortex shared the most similar chemical composition with 19 compounds, which corroborate the results of Zhao et al.
|Figure 5: Venn diagram of the number of compounds that identified in Mori Folium, Mori Ramulus, Mori Fructus and Mori Cortex|
Click here to view
The differences in types and content of active compounds are generally considered to be the key factors for the multiple efficacies of TCM. In this study, the differences in the chemical composition of the four medicines can be mainly attributed to flavonoids, Diels-Alder adducts, and 2-arylbenzofuran, which is consistent with a previous report. These compounds were obtained from the same source, but they demonstrated different efficacies. In this regard, further explanation could be made from the analysis of content determination and metabolic network pathways in future works.
Analysis of molecular docking with anti-inflammatory targets
According to the modern pharmacological research, four mulberry medicines all have anti-inflammatory activity. Therefore, to explore the anti-inflammatory effects through molecular docking of the various compounds identified in the aforementioned medicines, iNOS, TNF-α, IL-6, and IL-1 β were selected as the targets. The results showed that the shared compounds, namely, quercetin, chlorogenic acid, and isoquercitrin all had good docking effects on the aforementioned anti-inflammatory targets, which is consistent with the pharmacological activities of their monomeric compounds,,, as well the four medicines. Out of the top 10% of the compounds (7 compounds) with better docking effects on TNF-α and IL-6, 6 of them were identified in Mori Cortex. Mori Fructus had less of those compounds, which is consistent with the fact that it is not mainly used as anti-inflammatory drugs in clinical treatment, while Mori Cortex was.
The top 10% of the compounds docked into the binding sites of IL-1 β showed lower scores than that of other targets, which indicated that they were well bound. Out of the 10% of them, five compounds were identified in Mori Folium. Moreover, rutin, a shared compound identified in both Mori Folium and Mori Fructus, exerted 8 hydrogen bonds with 6 surrounding amino acid residues of IL-1 β, which implied that it is an excellent potential anti-inflammatory agent. Of note, recent pharmacological studies showed that rutin can effectively reduce the level of proinflammatory cytokines such as IL-1 β and TNF-α, regulate inflammation,, and play a protective role in liver and kidney poisoning, nerve injury and optic neuropathy, cardiovascular, breast tissue, and so on, which further corroborated our research results. Interestingly, cathafuran B showed good binding ability to amino acid residues of iNOS, TNF-α, and IL-6 which revealed that it is a potential anti-inflammatory agent among the compounds tested; nonetheless, there are only few studies conducted to enumerate its efficacy.
Analysis of molecular docking with antitussive targets
PDE 4B and β2 adrenergic receptors are frequently used as cellular targets for the treatment of pulmonary inflammation;, hence, the two were chosen as antitussive targets. In this study, among the top 10% of the compounds with better docking effect on PDE 4B and β2 adrenergic receptors, 11 compounds were identified in Mori Cortex, especially quinic acid and mulberrin U, which had the best binding activity with PDE 4B target and β2 adrenergic receptors, respectively, but only 2 or 3 compounds were identified in Mori Folium, Mori Ramulus, and Mori Fructus. This result is consistent with the traditional efficacy of Mori Cortex as the “antitussive and anti-asthmatic” medicine. For instance, Cai et al. found that the water extracts and 95% ethanol extracts of Mori Cortex inhibited the activity of PDE4. Wang et al. observed that the decoction of Mori Cortex has good effects of relieving cough and asthma, eliminating phlegm, and its effective fraction is present in 30% ethanolic extract. Moreover, total flavonoids, mulberroside A, and acetone extracts (identified as nonflavonoids) of Mori Cortex, have antitussive and anti-asthmatic effects. Based on the abovementioned findings, this study further highlights the ingredients with the effectiveness as an antitussive for Mori Cortex.
| Conclusion|| |
In this study, we systematically analyzed the chemical constituents of four medicinal parts of mulberry. A total of 77 compounds were identified from MMe and different polar fractions of water extracts, out of which 42 were flavonoids and 9 were 2-arylbenzofurans. Notably, thirty compounds were identified in Mori Folium, 27 compounds in Mori Ramulus, 23 compounds in Mori Fructus, and 46 compounds in Mori Cortex, and they had 14, 4, 3, and 26 compounds that were specific to them, respectively. Comparatively, Mori Ramulus and Mori Cortex had more similar chemical composition. The top 10% of the compounds with better docking effect to anti-inflammatory activity targets were mostly identified in Mori Cortex and the least were in Mori Fructus. Furthermore, the top 10% of compounds with better antitussive activity were 11 compounds identified in Mori Cortex, and only 2 or 3 compounds were identified in other three medicines. These results corroborate clinical application of the four medicines, which further explained the correlation between chemical composition and pharmacodynamics. The results of this study laid the foundation for pharmacodynamics research on distinct medicinal organs of mulberry, and also provided new insights in the research of many TCMs with different efficacies but with same origin.
We sincerely thank Prof. Chunlai Feng for his suggestions and carrying out molecular docking studies.
Financial support and sponsorship
This research was funded by the National Natural Science Foundation of China (Grant No. 81872961, 81573529), the key project at central government level: The ability establishment of sustainable use for valuable Chinese medicine resources (Grant No. 2060302).
Conflicts of interest
There are no conflicts of interest.
| References|| |
Committee NP, editor. Pharmacopoeia of Peoples Republic of China. Part 1. Beijing: Chinese Medical Science and Technology Press; 2015.
Ouyang Z, Chen J. Advances in studies on chemical constituents and pharmacological effects of Mori Folium. J Jiangsu Univ 2003;6:39-44.
Dong JX, Dong YX, Cai KZ. A review of the Mori Ramulus on its chemical and pharmacological studies. Mod Chin Med 2014;16:957-60.
Wang HW, Sheng BY, Lin C. Research progress on pharmacological action of Mori Cortex. J Chin Med 2019;34:1183-7.
Chen C, Ma WF. Advances in studies on chemical constituents and pharmacological effects of Mori Fructus. Psychologies 2020;15:232-3.
Zhao TT, Wei H, Chen LM, Wang ZM, Zhang QW, Zhao ZB, et al.
HPLC fingerprints of different medicinal parts of Morus alba
L. Chin Pharm J 2017;52:560-6.
Han M, Jiang HM, Ma YY. Analysis of volatile components of different medicinal parts of Morus alba
L. by HS-SPME-GC-MS. Mod Chin Med 2019;21:169-72.
Wang Z, Liu J, Yu Y, Chen Y, Wang Y. Modular pharmacology: The next paradigm in drug discovery. Expert Opin Drug Discov 2012;7:667-77.
Zhang FX, Li ZT, Li M, Yuan YL, Cui SS, Wang GH, et al.
An integrated strategy for revealing the pharmacological changes based on metabolites profiling and network pharmacology: Arctiin as an example. J Chromatogr B Analyt Technol Biomed Life Sci 2020;1157:122270.
Yang WY. Study on Herbal Species, Quality and Efficacy of Ramulus Mori and Cortex Mori. Chengdu: Chengdu University of Chinese Medicine; 2008.
Yang LH, Min F, Te Z, Guo ZF, Lu HD. Isolation of active compounds from Cortex Mori and its mechanism on anti-inflammatory. Chin Arch Tradit Chin Med 2016;34:3008-12.
Zheng CS, Yan PJ, Fu CL, Ye HZ, Wu GW, Li XH, et al. Verifying the anti-inflammatory and analgesic effects of Qianghuo from the compound-target network perspective. Rheumatism Arthritis 2017;6:10-4.
Zhang Z, Shi L. Anti-inflammatory and analgesic properties of cis-mulberroside A from Ramulus Mori. Fitoterapia 2010;81:214-8.
Ali N, Rashid S, Nafees S, Hasan SK, Shahid A, Majed F, et al.
Protective effect of chlorogenic acid against methotrexate induced oxidative stress, inflammation and apoptosis in rat liver: An experimental approach. Chem Biol Interact 2017;272:80-91.
Chen LD, Liu ZH, Zhang LF, Yao JN, Wang CF. Sanggenon C induces apoptosis of colon cancer cells via inhibition of NO production, iNOS expression and ROS activation of the mitochondrial pathway. Oncol Rep 2017;38:2123-31.
Yang LH, Zhao FM, Zhang T, Guo F, Lu HD. Isolation of active compounds from Cortex Mori and its mechanism on anti-inflammatory. Chin Arch Tradit Chin Med 2016;34:3008-12.
Ho TY, Lo HY, Liu IC, Lin KA, Liao YF, Lo YC, et al.
The protective effect of quercetin on retinal inflammation in mice: The involvement of tumor necrosis factor/nuclear factor-κB signaling pathways. Food Funct 2020;11:8150-60.
Özdemir S, Kucukler S, Çomaklı S, Kandemir FM. The protective effect of Morin against ifosfamide-induced acute liver injury in rats associated with the inhibition of DNA damage and apoptosis. Drug Chem Toxicol 2020;43:1-10.
Shi A, Shi H, Wang Y, Liu X, Cheng Y, Li H, et al.
Activation of Nrf2 pathway and inhibition of NLRP3 inflammasome activation contribute to the protective effect of chlorogenic acid on acute liver injury. Int Immunopharmacol 2018;54:125-30.
Lee J, Mandava S, Ahn SH, Bae MA, So KS, Kwon KS, et al.
Potential moracin M prodrugs strongly attenuate airway inflammation in vivo
. Biomol Ther (Seoul) 2020;28:344-53.
Lu Y. Study on the Chemical Composition of Ramulus Mori and Their Phosphodiesterase-4 Inhibitory Activity. Guangzhou: Guangzhou University of Chinese Medicine; 2015.
Kim JH, Doh EJ, Lee G. Quantitative comparison of the marker compounds in different medicinal parts of Morus alba
L. using high-performance liquid chromatography-diode array detector with chemometric analysis. Molecules 2020;25:5592.
Fang XY, Zhang YW, Xiao W, Zhao LG. Advance in preparation and research progress of isoquercitrin. Res Dev Nat Prod 2020;32:708-17.
Liu SW, Liu JY. Advances in the pharmacological effects of quercetin. Chin J Lung Dis 2020;13:104-06.
Seo CS, Lim HS, Jeong SJ, Ha H, Shin HK. HPLC-PDA analysis and anti-inflammatory effects of Mori Cortex Radicis. Nat Prod Commun 2013;8:1443-6.
Caglayan C, Kandemir FM, Darendelioğlu E, Yıldırım S, Kucukler S, Dortbudak MB. Rutin ameliorates mercuric chloride-induced hepatotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis. J Trace Elem Med Biol 2019;56:60-8.
Abdelfattah MS, Badr SE, Lotfy SA, Attia GH, Aref AM, Abdel Moneim AE, et al.
Rutin and selenium co-administration reverse 3-nitropropionic acid-induced neurochemical and molecular impairments in a mouse model of Huntington's disease. Neurotox Res 2020;37:77-92.
Taşlı NG, Uçak T, Karakurt Y, Keskin Çimen F, Özbek Bilgin A, Kurt N, et al.
The effects of rutin on cisplatin induced oxidative retinal and optic nerve injury: An experimental study. Cutan Ocul Toxicol 2018;37:252-7.
Topal İ, Özbek Bilgin A, Keskin Çimen F, Kurt N, Süleyman Z, Bilgin Y, et al.
The effect of rutin on cisplatin-induced oxidative cardiac damage in rats. Anatol J Cardiol 2018;20:136-42.
Su S, Li X, Li S, Ming P, Huang Y, Dong Y, et al.
Rutin protects against lipopolysaccharide-induced mastitis by inhibiting the activation of the NF-κB signaling pathway and attenuating endoplasmic reticulum stress. Inflammopharmacology 2019;27:77-88.
Xu ZB, Feng YL. Evaluation on the rational use of β2 receptor agonists. Eval Anal Drug-Use Hospit Chin 2007;5:325-8.
Cai YH, Cao ZY, Xie LX, Luo HB, Zhang CX, He XX. Inhibition of crude extracts of ten common anti-asthma traditional Chinese medicines towards phosphodiesterase 4. Drug Eval Res 2012;35:345-47.
Wang XL, Hao JL, Zhang GS, Sun YP, Cao YG, Zhang N, et al.
Study on antitussive, expectorant, antiasthmatic and antitussive effects of decoction and chemical components of Mori Cortex. Moderniz Tradit Chin Med Mater Med World Sci Technol 2014;16:1951-6.
Wei YY, Xu F, Xia C, Chen XW, Zhang GG. Antitussive and expectorant effects of the flavonoid of Cortex Mori. J Shenyang Pharm Univ 2009;26:644-7.
Kan QM, Kang N, Tian HT, Li CL, Qiu F, Li YL. Antitussive and antiasthmatic effects of mulberroside A. J Shenyang Pharm Univ 2006;6:388-91.
Feng BH, Su HC, Yang JJ. Pharmacological study of the acetone extract from Morus alba
L. on respiratory system. J Guangdong Pharm Univ 2005;1:47-9.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6], [Table 7], [Table 8], [Table 9]